Cadila Healthcare

Cadila Healthcare to sell stake in Windlas Healthcare to Windlas Biotech for Rs 99.44 cr

Read more

DBT and BIRAC recommend 16 proposals for funding support towards COVID-19 Research Consortium

Read more

India agrees to sell hydroxychloroquine to Malaysia to help fight COVID-19

Read more

Cadila Healthcare gets EIR from US FDA for its Ahmedabad facility

Read more

Cadila Healthcare’s Q3 net profit declines 27 pc to Rs 374 cr

Read more

US FDA completes inspection of Cadila Healthcare’s Ahmedabad facility

Read more

Cadila Healthcare board approves merger of four subsidiaries to consolidate pharma business

Read more

Cadila Healthcare gets EIR from US FDA for Baddi facility

Read more

Cadila Healthcare receives US FDA approval for schizophrenia drug

Read more

Notices issued to companies for introducing drugs without prior nod from NPPA: Government

Read more